MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

BioDelivery Sciences International Company Profile (NASDAQ:BDSI)

Consensus Ratings for BioDelivery Sciences International (NASDAQ:BDSI) (?)
Ratings Breakdown: 2 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $9.18 (304.53% upside)

Analysts' Ratings History for BioDelivery Sciences International (NASDAQ:BDSI)
Show:
DateFirmActionRatingPrice TargetActions
5/12/2016FBR & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Piper JaffrayReiterated RatingOverweight$6.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2016Cantor FitzgeraldDowngradeBuy -> Hold$9.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016LaidlawLower Price TargetBuy$17.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/27/2015Janney Montgomery ScottInitiated CoverageNeutral -> Neutral$7.00 -> $5.28View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2015William BlairReiterated RatingBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2014Summer StreetSet Price TargetBuy$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/9/2014Ladenburg ThalmannBoost Price TargetBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for BioDelivery Sciences International (NASDAQ:BDSI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/10/2016Q116($0.35)($0.36)$2.96 million$3.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2016Q415$0.55$0.19$52.40 million$32.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q315($0.34)($0.39)$1.56 million$1.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.31)($0.37)$3.29 million$1.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q115($0.20)($0.16)$10.80 million$13.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/16/2015Q414($0.33)($0.51)$4.00 million$2.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/11/2014($0.29)($0.39)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/15/2014($0.07)($0.14)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2014Q114($0.15)($0.11)$11.60 million$20.69 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2014($0.22)($0.33)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for BioDelivery Sciences International (NASDAQ:BDSI)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.40)($0.36)($0.38)
Q2 20162($0.34)($0.34)($0.34)
Q3 20163($0.33)($0.24)($0.30)
Q4 20163($0.28)($0.20)($0.24)
Q1 20171($0.21)($0.21)($0.21)
Q2 20171($0.19)($0.19)($0.19)
Q3 20171($0.16)($0.16)($0.16)
Q4 20171($0.14)($0.14)($0.14)
(Data provided by Zacks Investment Research)
Dividend History for BioDelivery Sciences International (NASDAQ:BDSI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for BioDelivery Sciences International (NASDAQ:BDSI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/21/2016Charles BramlageDirectorBuy8,850$2.82$24,957.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2016Barry I FeinbergDirectorBuy10,000$2.74$27,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2016Niraj VasishtCTOBuy1,000$2.80$2,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2016Paolantonio Ernest Robert DeCFOBuy4,000$2.60$10,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2015Francis E Odonnell JrDirectorSell50,000$6.01$300,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2015Thomas D'alonzoDirectorBuy4,528$5.52$24,994.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2015Francis E Odonnell JrDirectorSell20,000$6.43$128,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2015Paolantonio Ernest Robert DeCFOBuy1,650$6.20$10,230.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015William B StoneDirectorSell11,500$7.01$80,615.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2015Francis E Odonnell JrDirectorSell21,597$8.03$173,423.91View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2015Mark A SirgoCEOSell4,187$7.97$33,370.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2015Barry I FeinbergDirectorBuy2,000$7.84$15,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2015Barry I FeinbergDirectorBuy2,000$8.54$17,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2015Thomas D'alonzoDirectorBuy6,226$8.07$50,243.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/26/2014Francis E Odonnell JrDirectorSell70,000$12.00$840,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Mark A SirgoCEOBuy2,500$12.23$30,575.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2014Samuel P Sears JrDirectorSell7,853$15.03$118,030.59View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014William B StoneDirectorSell14,000$16.11$225,540.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2014Barry I FeinbergDirectorBuy1,000$15.18$15,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2014Mark A SirgoCEOBuy2,000$15.04$30,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Andrew L FinnEVPSell90,000$15.00$1,350,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2014Charles BramlageDirectorBuy1,800$13.85$24,930.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/25/2014Paolantonio Ernest Robert DeCFOBuy1,250$12.13$15,162.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2014Samuel P Sears JrDirectorSell5,000$12.33$61,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2014Francis E Odonnell JrDirectorSell125,000$11.04$1,380,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/26/2014Francis Odonnell, Jr.DirectorSell50,000$8.04$402,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2014Samuel Sears, Jr.DirectorSell4,000$9.00$36,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2014Andrew FinnEVPSell80,000$9.99$799,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2014William StoneDirectorSell35,000$10.00$350,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Andrew FinnEVPSell18,737$8.84$165,635.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Francis Odonnell, Jr.DirectorSell70,000$8.92$624,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Mark SirgoCEOSell42,000$8.92$374,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/24/2014Andrew FinnEVPSell143,679$9.03$1,297,421.37View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/24/2014James McnultySVPSell89,223$8.73$778,916.79View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/24/2014John SheaDirectorSell130,000$8.78$1,141,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/24/2014Mark SirgoCEOSell116,253$9.01$1,047,439.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2013Mark SirgoCEOBuy2,337$4.29$10,025.73View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2013Francis Odonnell, Jr.DirectorSell95,000$5.36$509,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2013Samuel P Sears JrDirectorSell2,000$5.37$10,740.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013Samuel P Sears JrDirectorSell7,500$5.05$37,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Andrew FinnEVPBuy5,000$4.58$22,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013Mark SirgoCEOBuy5,100$4.43$22,593.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013William StoneDirectorSell6,825$4.44$30,303.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013James McnultyCFOBuy5,000$4.50$22,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/21/2013Mark A SirgoCEOBuy3,400$4.30$14,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2013Francis E Odonnell JrDirectorSell72,689$4.36$316,924.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2013Samuel P Sears JrDirectorSell5,000$4.42$22,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/21/2012Andrew L FinnEVPBuy3,000$3.85$11,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/21/2012Mark A SirgoCEOBuy4,975$4.02$19,999.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for BioDelivery Sciences International (NASDAQ:BDSI)
DateHeadline
06/24/16 02:46 PMHow Analysts Feel About BioDelivery Sciences International, Inc. (NASDAQ:BDSI)? - Press Telegraph
06/23/16 04:19 PMBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Earnings Glance and Target Price Review - Engelwood Daily
06/23/16 04:19 PMStrong Sell Calls Recommendations For BioDelivery Sciences International, Inc. (NASDAQ:BDSI) At 0 - Investor Newswire
06/22/16 07:55 PMNew Broker Ratings For BioDelivery Sciences International, Inc. (BDSI) - FTSE News
06/22/16 07:55 PMBioDelivery Sciences International (NASDAQ:BDSI) Analyst Rating Consensus - TheFounders Daily
06/22/16 07:55 PMBioDelivery Sciences International, Inc. (NasdaqCM:BDSI) Stock Momentum Hits EXTREME Weakness - CML News
06/22/16 07:33 AMBioDelivery Sciences International, Inc. (NASDAQ:BDSI): Growth Forecast - RealistInvestor.com
06/21/16 07:32 AMBioDelivery Sciences International, Inc. (BDSI) Current Analyst Ratings - Fiscal Standard
06/20/16 02:48 PMCompany Shares of BioDelivery Sciences International Drops by -10.49% - Trade Calls
06/17/16 02:43 PMStrong Buy Calls Count For BioDelivery Sciences International, Inc. (NASDAQ:BDSI) At 5 - Investor Newswire
06/17/16 02:43 PMYesterday Trading Recap: Thermo Fisher Scientific Inc (NYSE:TMO) , BioDelivery Sciences International, Inc ... - Street Updates
06/16/16 08:47 AMEndo's (ENDP) Pain Drug Opana ER to Face FDA Panel in Fall -
06/13/16 10:58 AMETF’s with exposure to BioDelivery Sciences International, Inc. : June 13, 2016 -
06/13/16 10:48 AMStock's Earnings Activity: Wolverine World Wide Inc. (NYSE:WWW), BioDelivery Sciences International, Inc. (NASDAQ ... - Beacon Chronicle
06/10/16 11:14 AMKeep an eye on Price Trends: BioDelivery Sciences International, Inc. (NASDAQ:BDSI) , Zimmer Biomet Holdings, Inc ... - Street Updates
06/09/16 11:44 AMAnalyst Recommendations on These Stocks: LKQ Corp. (NASDAQ:LKQ), BioDelivery Sciences International, Inc ... - Beacon Chronicle
06/08/16 09:10 PMAttentive Stocks in Active Notes- UnitedHealth Group (NYSE:UNH), BioDelivery Sciences International (NASDAQ:BDSI ... - Seneca Globe
06/08/16 09:10 PMBioDelivery Sciences International Inc. (BDSI) Jumps 12.74% on June 08 - Equities.com
06/08/16 03:15 PMStock's Earnings Analysis Report: BioDelivery Sciences International, Inc. (NASDAQ:BDSI), Unum Group (NYSE:UNM) - Beacon Chronicle
06/08/16 11:17 AMBIODELIVERY SCIENCES INTERNATIONAL INC. (NASDAQ:BDSI) Financial Condition Compared to S&P 500 - CML News
06/08/16 11:17 AMBioDelivery Sciences International Inc. (BDSI) Jumps 7.02% on June 07 - Equities.com
06/08/16 06:28 AMBioDelivery Sciences to Present at the William Blair Annual Growth Stock Conference - [at noodls] - RALEIGH, N.C., June 8, 2016/PRNewswire / -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) will present at the William Blair Annual Growth Stock Conference. The presentation, which will be webcast, ...
06/06/16 02:39 PMEarnings Expectation Watch List: BioDelivery Sciences International, Inc. (NASDAQ:BDSI), Post Holdings, Inc. (NYSE ... - Beacon Chronicle
06/04/16 11:17 AMBioDelivery Sciences International Inc. (BDSI) Jumps 6.45% on June 03 - Equities.com
06/03/16 02:52 PMBroker Watchlist: BioDelivery Sciences International, Inc. (BDSI) - Share Trading News
06/02/16 06:05 AMBioDelivery Sciences to Present at the Jefferies 2016 Healthcare Conference - [at noodls] - RALEIGH, N.C., June 2, 2016/PRNewswire / -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer, will present at the Jefferies ...
06/01/16 11:19 AMEarnings Overview: BioDelivery Sciences International, Inc. (NASDAQ:BDSI), Intrepid Potash, Inc. (NYSE:IPI) - Beacon Chronicle - Beacon ChronicleEarnings Overview: BioDelivery Sciences International, Inc. (NASDAQ:BDSI), Intrepid Potash, Inc. (NYSE:IPI)Beacon ChronicleLast Trade: The Company closed its last session at $2.25 with the gain of 6.64%. The market capitalization of the company is $119.43 Million, with the average Volume of 1.28 Million. The stock currently has its 52-Week High range of $9.91 and 52-week ...and more »
05/31/16 08:31 PMBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Stock Update & Estimates - Stock Tick Tock - BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting BioDelivery Sciences International, Inc. (NASDAQ:BDSI) to post earnings of $-0.31 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report ...and more »
05/31/16 02:52 PMPrice Review of Stocks: VWR Corporation (NASDAQ:VWR) , BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Street Updates - Price Review of Stocks: VWR Corporation (NASDAQ:VWR) , BioDelivery Sciences International, Inc. (NASDAQ:BDSI)Street UpdatesBioDelivery Sciences International, Inc. (NASDAQ:BDSI) after beginning at $2.06, closed at $2.11 by building up +0.96% in recent trading session. Most recent session's volume of 543.05 thousand shares lower than its average volume of 1.28 million shares.and more »
05/31/16 02:52 PMBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Quarterly EPS Estimate At $-0.2800 - Investor Newswire - BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Quarterly EPS Estimate At $-0.2800Investor NewswireFirst Call stated that BioDelivery Sciences International, Inc. (NASDAQ:BDSI) can touch $8.6300 in coming one year. For the next quarter, the per-share earnings target is $-0.2800 and for ongoing fiscal at $-1.1900. EPS target for next year is $-0.6500 ...and more »
05/30/16 02:43 PMNext Weeks Broker Price Targets For BioDelivery Sciences International, Inc. (BDSI) - Share Trading News - Next Weeks Broker Price Targets For BioDelivery Sciences International, Inc. (BDSI)Share Trading News05/11/2016 – BioDelivery Sciences International, Inc. was downgraded to “hold” by analysts at Cantor Fitzgerald. They now have a USD 5 price target on the stock. 05/04/2016 – BioDelivery Sciences International, Inc. had its “outperform” rating ...Alden Global Capital Exits Position in BioDelivery Sciences International (BDSI)Market Digestall 2 news articles »
05/23/16 02:40 PMEye-Catching Stocks: BioDelivery Sciences International, Inc. (NASDAQ:BDSI), Bristol-Myers Squibb Co (NYSE:BMY ... - The Point Review - The Point ReviewEye-Catching Stocks: BioDelivery Sciences International, Inc. (NASDAQ:BDSI), Bristol-Myers Squibb Co (NYSE:BMY ...The Point ReviewShares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) fell -1.28% to $1.92 at 11:54 AM EDT. The stock attained the volume of 806,507 shares recently versus average trading volume of 1.13 Million shares. If we take a look on its volatility, 7 ...Earnings Estimates Under Spotlight: BioDelivery Sciences International (BDSI)CWRU ObserverStocks Hitting 52-Week LowsBenzingaLatest Analyst Reports On BioDelivery Sciences International, Inc.Risers & FallersStreet Updatesall 7 news articles »
05/23/16 07:31 AMNotable Moving HC Stocks: BioDelivery Sciences International, Inc. (NASDAQ:BDSI), GlaxoSmithKline plc (ADR ... - share market updates (press release) - Notable Moving HC Stocks: BioDelivery Sciences International, Inc. (NASDAQ:BDSI), GlaxoSmithKline plc (ADR ...share market updates (press release)Shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) ended Friday session in red amid volatile trading. The shares closed down -0.02 points or -1.02% at $1.95 with 839,335.00 shares getting traded. Post opening the session at $2.01, the ...Stock's Move to Focus: Oncothyreon Inc. (NASDAQ:ONTY) , BioDelivery Sciences International, Inc. (NASDAQ:BDSI)Street Updatesall 3 news articles »
05/22/16 02:29 PMHealthcare Stock Update: BioDelivery Sciences International (BDSI) - News Oracle - Healthcare Stock Update: BioDelivery Sciences International (BDSI)News OracleBy looking at BioDelivery Sciences International, Inc. (NASDAQ:BDSI) YTD (year to date) performance, the stock shows Negative value of -58.87%. If the YTD value is Negative, it means that the stock is trading poorly. If the YTD value is Positive, this ...BioDelivery Sciences International, Inc. (NASDAQ:BDSI) One-Year Price Target Estimate At $8.63Investor Newswireall 3 news articles »
05/21/16 02:36 PMRevenue Update on BioDelivery Sciences International(NASDAQ:BDSI) - Trade Calls - Revenue Update on BioDelivery Sciences International(NASDAQ:BDSI)Trade CallsBioDelivery Sciences International(NASDAQ:BDSI) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 10, 2016. Company reported revenue of $3.04M. Analysts estimated a revenue of $2.96M.
05/20/16 02:41 PMTrending Tickers: American Eagle Outfitters, (NYSE:AEO), BioDelivery Sciences (NASDAQ:BDSI), Ignite Restaurant ... - KC Register - Trending Tickers: American Eagle Outfitters, (NYSE:AEO), BioDelivery Sciences (NASDAQ:BDSI), Ignite Restaurant ...KC RegisterOn 11 May, BioDelivery Sciences International, Inc. (NASDAQ:BDSI) and Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced the signing of a licensing agreement under which BDSI is granting the exclusive rights to develop and commercialize ...
05/20/16 02:41 PMBioDelivery Sciences International, Inc. (NASDAQ:BDSI) One-Year Price Target Estimate At $8.63 - Investor Newswire - BioDelivery Sciences International, Inc. (NASDAQ:BDSI) One-Year Price Target Estimate At $8.63Investor NewswireThe 52-week price target of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) is set at $8.63 after First Call completed its market based survey. It has estimated EPS of $-0.28 for approaching quarter and $-1.19 for ongoing year. The EPS estimate ...Healthcare Stock Update: BioDelivery Sciences International (BDSI)News OracleCantor Fitzgerald Downgrades BioDelivery Sciences International to Hold with Price Target $5.00Trade Callsall 3 news articles »
05/19/16 07:44 PMBioDelivery Sciences International, Inc. (NASDAQ:BDSI) Hovering Around $2.03 - Investor Newswire - BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Hovering Around $2.03Investor NewswireOn performing technical analysis of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) stock, it is noted that the stock is $-1.16 points away -37.03% from its fifty-day MA of $3.14. It is $-2.12 or -51.76% away $4.10, the 200-day MA (Moving ...Recent Update on Price Movements: Enzon Pharmaceuticals, Inc. (NASDAQ:ENZN) , BioDelivery Sciences ...Street Updatesall 2 news articles »
05/19/16 06:02 PMETF’s with exposure to BioDelivery Sciences International, Inc. : May 19, 2016 -
05/19/16 12:04 PMBIODELIVERY SCIENCES INTERNATIONAL INC Financials -
05/18/16 10:23 AMBioDelivery Sciences International, Inc. :BDSI-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/17/16 03:18 PMBIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD -
05/14/16 02:45 PMBioDelivery Sciences International Inc. (BDSI) Drops 5.5% on May 12 - Equities.com - NewsWay 21BioDelivery Sciences International Inc. (BDSI) Drops 5.5% on May 12Equities.comBioDelivery Sciences International Inc. (BDSI) was one of the Russell 2000's biggest losers for Thursday May 12 as the stock slid 5.5% to $2.06, a loss of $-0.12 per share. Starting at an opening price of $2.21 a share, the stock traded between $2.01 ...Stock to Watch: BioDelivery Sciences International, Inc. (NASDAQ:BDSI)CWRU ObserverHealthcare Stock to target: BioDelivery Sciences International, Inc. (NASDAQ:BDSI) , Lexicon Pharmaceuticals, Inc ...Is storiesCantor Doesn't Think BioDelivery Sciences Should Be Cutting To Grow, Downgrades Stock To HoldBenzingaRisers & Fallers -Zergwatch -NewsWay 21all 65 news articles »
05/13/16 02:53 PMCan BioDelivery Sciences International, Inc. (NASDAQ:BDSI)'s Touch $9.00 In Coming Year? - Investor Newswire - Can BioDelivery Sciences International, Inc. (NASDAQ:BDSI)'s Touch $9.00 In Coming Year?Investor NewswireBioDelivery Sciences International, Inc. (NASDAQ:BDSI) has a 52-week price target of $9.00 based on the recommendations collected by First Call. The firm's mean EPS in the last one year was $-0.92. The analysts are now projecting earnings of $-0.28 for ...and more »
05/12/16 04:34 PMBioDelivery-Collegium Collaborate for Onsolis in U.S. -
05/12/16 02:52 PMPopular Healthcare Stocks: Zoetis Inc. (NYSE:ZTS) , BioDelivery Sciences International, Inc. (NASDAQ:BDSI) - Is stories - Is storiesPopular Healthcare Stocks: Zoetis Inc. (NYSE:ZTS) , BioDelivery Sciences International, Inc. (NASDAQ:BDSI)Is storiesOn 5/11/2016, shares of Zoetis Inc. (NYSE:ZTS) fell -1.20% in last session and lastly traded at $46.00. The company exchanged volume remained 5.6 million shares versus its average volume of 4.53 million shares. Over the 52-week trading session, the ...Analyst Recent Rating Update: Zoetis Inc (NYSE:ZTS), BioDelivery Sciences International, (NASDAQ:BDSI)WsNews 4investorsall 5 news articles »
05/12/16 02:52 PMHC Stocks Opinion: Herbalife Ltd. (HLF), BioDelivery Sciences International Inc. (BDSI), Apricus Biosciences Inc (APRI) - share market updates (press release) - HC Stocks Opinion: Herbalife Ltd. (HLF), BioDelivery Sciences International Inc. (BDSI), Apricus Biosciences Inc (APRI)share market updates (press release)Shares of Herbalife Ltd. (NYSE:HLF) ended Wednesday session in red amid volatile trading. The shares closed down -0.33 points or -0.53% at $62.40 with 1.02 million shares getting traded. Post opening the session at $62.73, the shares hit an intraday ...and more »
05/12/16 09:40 AMRaleigh's BioDelivery license painkiller to Collegium Pharmaceutical -
05/11/16 04:07 PMBioDelivery Sciences and Collegium Pharmaceutical Announce the Signing of a Licensing Agreement for ONSOLIS® in the U.S. - [at noodls] - RALEIGH, N.C., May 11, 2016/PRNewswire / -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) and Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced the signing of a licensing agreement ...
05/11/16 04:07 PMCollegium Licenses the U.S. rights to ONSOLIS® from BioDelivery Sciences - [at noodls] - CANTON, Mass., May 11, 2016 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today the licensing of the U.S. rights to develop and commercialize ONSOLIS (fentanyl buccal soluble ...
About BioDelivery Sciences International

BioDelivery Sciences International logoBioDelivery Sciences International, Inc. is a specialty pharmaceutical company. The Company develops and commercializes, either on its own or in partnerships with third parties, applications of approved therapeutics to address unmet medical needs using drug delivery technologies. The Company develops pharmaceutical products aimed principally in the areas of pain management and addiction. The Company's products and certain of its product candidates utilize the BioErodible MucoAdhesive (BEMA) drug delivery technology, a small, erodible polymer film for application to the buccal mucosa (the lining inside the cheek). The Company's United Sates Food and Drug Administration (FDA) approved product, ONSOLIS (fentanyl buccal soluble film), as well as its approved product BUNAVAIL (buprenorphine and naloxone buccal film) and its product candidate, BELBUCA utilize its BEMA technology.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: BDSI
  • CUSIP: 09060J10
Key Metrics:
  • Previous Close: $2.27
  • 50 Day Moving Average: $2.28
  • 200 Day Moving Average: $3.46
  • P/E Ratio: N/A
  • P/E Growth: -0.08
  • Market Cap: $121.66M
  • Current Quarter EPS Consensus Estimate: $-1.19 EPS
Additional Links:
BioDelivery Sciences International (NASDAQ:BDSI) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha